Treatment with lamin Gel significantly improved ulcer closure rates, achieving a median area closure of 98.5% compared to 60.8% for the control group
In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid
Our result suggests that HBOT is safe and should be offered to CRAO patients who present to the hospital within 24 hours of symptom onset
Whartons Jelly, sourced from umbilical cord tissue, is an advanced regenerative matrix rich in growth factors, cytokines, hyaluronic acid, and extracellular matrix components
Research suggests that the medication, a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, originally developed to manage Type 2 diabetes, may be able to treat a wide range of conditions involving impulse control, like binge eating disorder.But although there may be tantalizing clues for helping patients with unwanted impulses, GLP-1 and GIP inhibitors may not be optimally designed to treat them sufficiently and need further research, according to a case study from the Perelman School of Medicine at the University of Pennsylvania, published today in Nature Medicine
